These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38246528)

  • 81. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.
    McGirt MJ; Garces Ambrossi GL; Huang J; Tamargo RJ
    J Neurosurg; 2009 May; 110(5):968-74. PubMed ID: 19199459
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Quantitative Modeling of External Ventricular Drain Output to Predict Shunt Dependency in Aneurysmal Subarachnoid Hemorrhage: Cohort Study.
    Perry A; Graffeo CS; Kleinstern G; Carlstrom LP; Link MJ; Rabinstein AA
    Neurocrit Care; 2020 Aug; 33(1):218-229. PubMed ID: 31820290
    [TBL] [Abstract][Full Text] [Related]  

  • 84. An update of predictors of cerebral infarction after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis.
    Florez WA; Martinez-Perez R; Deora H; Joaquim AF; García-Ballestas E; Quiñones-Ossa GA; Rivas-Palacios C; Agrawal A; Serrato SA; Jabbour P; Moscote-Salazar LR
    J Neurosurg Sci; 2023 Feb; 67(1):1-9. PubMed ID: 36112119
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Vasospasm risk following aneurysmal subarachnoid hemorrhage in older adults.
    Pavelka M; Necarsulmer J; Ho J; Sasaki-Adams D
    J Neurosurg; 2023 Nov; 139(5):1302-1310. PubMed ID: 37119113
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting Hemoglobin to Reduce Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
    Zeineddine HA; Honarpisheh P; McBride D; Pandit PKT; Dienel A; Hong SH; Grotta J; Blackburn S
    Transl Stroke Res; 2022 Oct; 13(5):725-735. PubMed ID: 35157256
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article.
    Fountas KN; Tasiou A; Kapsalaki EZ; Paterakis KN; Grigorian AA; Lee GP; Robinson JS
    Neurosurg Focus; 2009 May; 26(5):E22. PubMed ID: 19409001
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of Statins on Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
    Zhang BF; Song JN; Wang J; Ma XD; Zhang ST; Zhao JJ; Shu K; Sun P; Zhao YL
    Turk Neurosurg; 2015; 25(6):850-7. PubMed ID: 26617132
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Time trends in the risk of delayed cerebral ischemia after subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Rigante L; van Lieshout JH; Vergouwen MDI; van Griensven CHS; Vart P; van der Loo L; de Vries J; Vinke RS; Etminan N; Aquarius R; Gruber A; Mocco J; Welch BG; Menovsky T; Klijn CJM; Bartels RHMA; Germans MR; Hänggi D; Boogaarts HD
    Neurosurg Focus; 2022 Mar; 52(3):E2. PubMed ID: 35231892
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-Analysis.
    Mishra S; Garg K; Gaonkar VB; Singh PM; Singh M; Suri A; Chandra PS; Kale SS
    World Neurosurg; 2021 Nov; 155():41-53. PubMed ID: 34339892
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage.
    Mijiti M; Mijiti P; Axier A; Amuti M; Guohua Z; Xiaojiang C; Kadeer K; Xixian W; Geng D; Maimaitili A
    PLoS One; 2016; 11(12):e0168657. PubMed ID: 27977801
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Electroencephalography for detection of vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a retrospective analysis and systematic review.
    Scherschinski L; Catapano JS; Karahalios K; Koester SW; Benner D; Winkler EA; Graffeo CS; Srinivasan VM; Jha RM; Jadhav AP; Ducruet AF; Albuquerque FC; Lawton MT
    Neurosurg Focus; 2022 Mar; 52(3):E3. PubMed ID: 35231893
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A Propensity Score Analysis of the Impact of Dexamethasone Use on Delayed Cerebral Ischemia and Poor Functional Outcomes After Subarachnoid Hemorrhage.
    Mohney N; Williamson CA; Rothman E; Ball R; Sheehan KM; Pandey AS; Fletcher JJ; Jacobs TL; Thompson BG; Rajajee V
    World Neurosurg; 2018 Jan; 109():e655-e661. PubMed ID: 29061461
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Unaccounted for enteral volume loss linked to delayed cerebral ischemia after subarachnoid hemorrhage.
    Gelder CL; Bautista M; Awan SA; Anderson IA
    Neurosurg Focus; 2022 Mar; 52(3):E5. PubMed ID: 35231895
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cilostazol Administration for Subarachnoid Hemorrhage: A Meta-analysis of Randomized Controlled Trials.
    Chen H; Luo W; Cai X; Cai J
    Clin Neuropharmacol; 2022 Sep-Oct 01; 45(5):111-116. PubMed ID: 36162042
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Lower incidence of cerebral infarction correlates with improved functional outcome after aneurysmal subarachnoid hemorrhage.
    Vergouwen MD; Etminan N; Ilodigwe D; Macdonald RL
    J Cereb Blood Flow Metab; 2011 Jul; 31(7):1545-53. PubMed ID: 21505477
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Identification of specific age groups with a high risk for developing cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Malinova V; Schatlo B; Voit M; Suntheim P; Rohde V; Mielke D
    Neurosurg Rev; 2016 Jul; 39(3):429-36. PubMed ID: 26940102
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Endovascular treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage: predictors of outcome and retreatment.
    Sokolowski JD; Chen CJ; Ding D; Buell TJ; Raper DM; Ironside N; Taylor DG; Starke RM; Liu K
    J Neurointerv Surg; 2018 Apr; 10(4):367-374. PubMed ID: 29079662
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage.
    Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G
    J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.